Development and validation of prognostic models in metastatic breast cancer: a GOCS study.
The significance of several prognostic factors and the magnitude of their influence on response rate and survival were assessed by means of uni- and multivariate analyses in 362 patients with stage IV (UICC) breast carcinoma receiving combination chemotherapy as first systemic treatment over an 8-year period. Univariate analyses identified performance status and prior adjuvant radiotherapy as predictors of objective regression (OR), whereas the performance status, prior chemotherapy and radiotherapy (adjuvants), white blood cells count, SGOT and SGPT levels, and metastatic pattern were significantly correlated to survival. In multivariate analyses favorable characteristics associated to OR were prior adjuvant radiotherapy, no prior chemotherapy and postmenopausal status. Regarding survival, the performance status and visceral involvement were selected by the Cox model. The predictive accuracy of the logistic and the proportional hazards models was retrospectively tested in the training sample, and prospectively in a new population of 126 patients also receiving combined chemotherapy as first treatment for metastatic breast cancer. A certain overfitting to data in the training sample was observed with the regression model for response. However, the discriminative ability of the Cox model for survival was clearly confirmed.
Rabinovich
M
M
Hospital Provincial, Neuquén, Argentina.
Vallejo
C
C
Bianco
A
A
Perez
J
J
Machiavelli
M
M
Leone
B
B
Romero
A
A
Rodriguez
R
R
Cuevas
M
M
Dansky
C
C
D000704:Analysis of Variance; D001943:Breast Neoplasms / Q000401:mortality* / Q000556:secondary; D005260:Female; D006801:Humans; D008954:Models, Biological; D015999:Multivariate Analysis; D011379:Prognosis